Zeinab Abou Yehia
Overview
Explore the profile of Zeinab Abou Yehia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yehia Z, Sherwani Z, Chakraborty M, Ohri N, Grann A, Eladoumikdachi F, et al.
Int J Radiat Oncol Biol Phys
. 2024 Sep;
121(2):333-340.
PMID: 39241809
Purpose: A radiation therapy (RT) boost to the tumor bed is an important component of breast-conserving therapy in early breast cancer. This prospective phase 2 study assessed the feasibility of...
2.
Kumar R, Krupa K, Yehia Z, Kumar S, Potdevin L, Eladoumikdachi F, et al.
Adv Radiat Oncol
. 2024 Jan;
9(1):101324.
PMID: 38260231
Purpose: Accelerated partial breast irradiation (APBI) is one of the standard treatment options in early-stage node negative breast cancer in selected patients. However, the optimal dose fractionation schedule still represents...
3.
Yashar C, Khan A, Chen P, Einck J, Poppe M, Li L, et al.
Pract Radiat Oncol
. 2023 May;
13(4):314-320.
PMID: 37140504
Purpose: Shorter courses of breast radiotherapy are offered as an alternative to 4 weeks of whole-breast irradiation after lumpectomy, including brachytherapy. A prospective phase 2multi-institution clinical trial to study 3-fraction...
4.
Yehia Z, Punglia R, Wong J
Semin Radiat Oncol
. 2022 Jun;
32(3):237-244.
PMID: 35688522
Postmastectomy radiation therapy (PMRT) is a mainstay of local therapy for many breast cancer patients. Patients undergoing mastectomy typically are offered options for breast reconstruction. For patients who are candidates...
5.
Yehia Z, Yoon J, Sayan M, Kumar S, Hathout L, Kowzun M, et al.
Anticancer Res
. 2022 May;
42(6):2961-2965.
PMID: 35641254
Aim: To evaluate the impact of BioZorb, a 3D-bioabsorbable marker, on the tumor-bed boost volume and dosimetric parameters in adaptive boost planning for breast cancer. Patients And Methods: Records were...
6.
Shbib Dabaja B, Boyce-Fappiano D, Dong W, Damron E, Fang P, Gunther J, et al.
Clin Transl Radiat Oncol
. 2022 May;
35:64-69.
PMID: 35601797
Purpose: Therapeutic improvements for Hodgkin's Lymphoma (HL) has resulted in excellent survival outcomes. Thus, patients are increasing susceptible to developing secondary malignancy (SM) a feared iatrogenic complication. Materials & Methods:...
7.
Sayan M, Yehia Z, Jan I, Gupta A, Vergalasova I, Reviello M, et al.
Anticancer Res
. 2021 Dec;
42(1):53-57.
PMID: 34969708
Background/aim: To evaluate the change in lumpectomy cavity (LPC) volume during hypofractionated radiation (Hypo-RT) and assess the dosimetric benefits of adaptive boost planning on normal tissue exposure in breast cancer...
8.
Pendyala P, Goglia A, Mattes M, Grann A, Huang D, Wagman R, et al.
Adv Radiat Oncol
. 2021 Mar;
6(3):100680.
PMID: 33686375
Purpose: This study aimed to define how the coronavirus disease of 2019 (COVID-19) pandemic affected the role, timing, and delivery of radiation therapy (RT) in a high-prevalence region at the...
9.
Sayan M, Yehia Z, Ohri N, Haffty B
Adv Radiat Oncol
. 2021 Jan;
6(1):100618.
PMID: 33490735
Purpose: To provide an overview of the major randomized trials that support the use of hypofractionated post-mastectomy radiation therapy for locally advanced breast cancer patients. Methods And Materials: PubMed was...
10.
Sayan M, Ohri N, Lee A, Yehia Z, Gupta A, Byun J, et al.
Front Oncol
. 2019 Dec;
9:1369.
PMID: 31867278
Strong mentorship has been shown to improve mentee productivity, clinical skills, medical knowledge, and career preparation. We conducted a survey to evaluate resident satisfaction with mentorship within their radiation oncology...